Tender for TENDER FOR THE DRUGS, IV FLUIDS DISPOSABLES, SUTURES AND RARE DISEASE DRUGS FOR THEYEAR 2026-27

Sharing tender

Tender For The Drugs, Iv Fluids Disposables, Sutures And Rare Disease Drugs For The Year 2026-27 - Creon Capsules,Diazoxide 50 Mg,Calcitriol 1 25Oh Vit D,Phosphorus Sachet,Long Acting Octreotide 30 Mg,Long Acting Octreotide 20 Mg,Diazoxide 25 Mg,Inj. Celestrase (Human C1- Estcrase Inhibitor) 500 Iu,Risdiplam Syrup 0.75Mg/Ml,Eliglustat Cap 84 Mg,Colchicine 0.5 Mg,Tofacitinib Tab 10 Mg,Tofacitinib Tab 5 Mg,Infliximab Inj 100 Mg,Uncooked Corn Starch With Vitamin D & Minerals,Galactose Free Diet Cmd, Gg1 (Glucose-Galactose Free),Phenyalanine And Tyrosine Free Diet More Than 3Yr (Stage 2) Qty-Tyros-2,Phenyalanine And Tyrosine Free Diet Less Than 3Yr (Stage 1) Qty Tyros-1,Non Essential Amino Acid Free Diet More Than 3Yr (Stage 2) Qty-Ucd-2,Non-Essential Amino Acid Free Diet Less Than 3Yr (Stage 1) Qty -Ucd-1,Phenyalanine Free Diet More Than 3Yr (Stage 2) Qty- Pku-2,3,Phenyalanine Free Diet Less Than 3Yr (Stage 1) Qty Pku-1,Protien & Amino Acid Free Diet (With Or Without Fat) More Than 3Yr (Stage 2) Qty -Amd-2,Protien & Amino Acid Free Diet (With Or Without Fat) Less Than 3Yr (Stage 1) Qty- Amd-1,Isoleucine, Methionine, Threonine & Valine Free Diet More Than 3Yr (Stage 2) Qty-Mma/Pa-2,Isoleucine, Methionine, Threonine & Valine Free Diet Less Than 3Yr (Stage 1) Qty -Mma/Pa-1,Leucine Free Diet More Than 3Yr (Stage 2) Qty -Iva-2,Leucine Free Diet Less Than 3Yr (Stage 1) Qty -Iva-1,Methionine Free Diet More Than 3Yr (Stage 2) Qty -Hcy-2,Methionine Free Diet Less Than 3Yr (Stage 1) Qty- Hcy-1,Lysine & Tryptophan Free Diet More Than 3Yr (Stage 2) Qty -Ga-2,Lysine & Tryptophan Free Diet Less Than 3Yr (Stage 1) Qty -Ga-1,Isoleucine, Leucine & Valine Free Diet More Than 3Yr (Stage 2) Qty -Msud -2,Isoleucine, Leucine & Valine Free Diet Less Than 3Yr (Stage 1) Qty- Msud -1,Adalimumab Inj 40 Mg /0.4 Ml,Adalimumab Inj 40 Mg /0.8 Ml,Inj Tocilizumab Or Biosimilar 400 Mg,Inj Tocilizumab Or Biosimilar 200 Mg,Inj Tocilizumab Or Biosimilar 80 Mg,Inj Growth Hormone,Pharmacological Agents Required To Provide Enzyme Replacement Therapy For Patient With Gaucher Disease Type-1 Caused By Beta- Glucosidase Enzyme Deficiency,Pharmacological Agents Equired To Provide Enzyme Replacement Therepy For Patient With Pompe Disease,Pharmacological Agents Required To Provide Enzyme Replacement Therapy For Patient With Gaucher Disease Type-3 Caused By Beta- Glucosidase Enzyme Deficiency,Inj Etanercept Or Biosimilar 25Mg,Tab Diazaoxide 25Mg,Iv Immunoglobulin 5%,Iv Immunoglobulin 10%,Cap Trientine,Cap Nitisinone 10Mg,Cap Nitisinone 5Mg,Cap Nitisinone 2Mg